Activity of a Phage Collection Against Staphylococci from Periprosthetic Joint Infections
Background: Phages are being assessed for treatment of periprosthetic joint infection (PJI). Staphylococci are the most common cause of PJI. Phages are traditionally considered to be strain-specific and restricted to specific species. We aimed to assess the in vitro activity of a collection of staphylococcal phages against a selection of clinical Staphylococcus isolates recovered from PJI over a 20-year period. Methods: The activity of 37 staphylococcal phages was evaluated against 204 staphylococcal isolates, including 102 Staphylococcus aureus, 81 Staphylococcus epidermidis , and 21 Staphylococcus lugdunensis , using a tetrazolium dye–based metabolic assay. Standardized inocula of bacteria and phage were incubated over 48 hours. Growth inhibition ≥8 hours was considered indicative of phage activity. Results: A total of 7,548 phage-isolate pairs were assessed. Overall, 31 of 37 phages had activity against at least 1 isolate. The most broadly active phage showed activity against 50 of 195 isolates (26%) tested. Twenty-three phages showed cross-species activity, with 11 phages active against all 3 Staphylococcus species, and 12 phages active against 2 species. Of all S. aureus isolates tested, 61% were susceptible to at least 1 phage, while 31% and 76% of S. epidermidis and S. lugdunensis isolates were susceptible to at least 1 phage, respectively. Conclusions: This is the largest library of phages evaluated against staphylococci from PJI. Results show that staphylococcal phages can have cross-species activity, suggesting that phage libraries may offer cross-species coverage of clinically encountered staphylococcal isolates from PJI. Level of Evidence: Level V . Mechanism-based reasoning. See Instructions for Authors for a complete description of levels of evidence.
Authors
- Joseph Fackler (ORCID: https://orcid.org/0000-0002-9015-9546)
- Martin Lee (ORCID: https://orcid.org/0000-0002-6004-3622)
- Sebastian Herren (ORCID: https://orcid.org/0009-0002-2570-4250)
- Gina A. Suh (ORCID: https://orcid.org/0000-0001-7434-6897)
- Kerryl E. Greenwood‐Quaintance (ORCID: https://orcid.org/0000-0003-3760-4310)
- Robin Patel (ORCID: https://orcid.org/0000-0001-6344-4141)
- Krupa Parmar (ORCID: https://orcid.org/0000-0003-2825-7185)
- James J. Vaillant (ORCID: https://orcid.org/0000-0001-5756-418X)
- Jay‐Hyun Jo (ORCID: https://orcid.org/0000-0002-2039-3425)
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Florida (US)
- Io Therapeutics (United States) (US)
Publication Details
- Journal
- JBJS Open Access
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2106/jbjs.oa.23.00174
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00